Literature DB >> 10521790

Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden.

V Chajès1, K Hultén, A L Van Kappel, A Winkvist, R Kaaks, G Hallmans, P Lenner, E Riboli.   

Abstract

The study of the relationship between dietary intake of fatty acids and the risk of breast cancer has not yielded definite conclusions with respect to causality, possibly because of methodological issues inherent to nutritional epidemiology. To evaluate the hypothesis of possible protection of n-3 polyunsaturated fatty acids (PUFA) against breast cancer in women, we examined the fatty-acid composition of phospholipids in pre-diagnostic sera of 196 women who developed breast cancer, and of 388 controls matched for age at recruitment and duration of follow-up, in a prospective cohort study in Umeâ, northern Sweden. Individual fatty acids were measured as a percentage of total fatty acids, using capillary gas chromatography. Conditional logistic-regression models showed no significant association between n-3 PUFA and breast-cancer risk. In contrast, women in the highest quartile of stearic acid had a relative risk of 0.49 (95% confidence interval, 0.22-1.08) compared with women in the lowest quartile (trend p = 0.047), suggesting a protective role of stearic acid in breast-cancer risk. Besides stearic acid, women in the highest quartile of the 18:0/18:1 n-9c ratio had a relative risk of 0.50 (95% confidence interval, 0.23-1.10) compared with women in the lowest quartile (trend p = 0.064), suggesting a decrease in breast-cancer risk in women with low activity of the enzyme delta 9-desaturase (stearoyl CoA desaturase), which may reflect an underlying metabolic profile characterized by insulin resistance and chronic hyper-insulinemia. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521790     DOI: 10.1002/(sici)1097-0215(19991126)83:5<585::aid-ijc2>3.0.co;2-z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  38 in total

1.  Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women.

Authors:  Jonas Manjer; Robert Johansson; Per Lenner
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women.

Authors:  A Manni; J P Richie; S E Schetter; A Calcagnotto; N Trushin; C Aliaga; K El-Bayoumy
Journal:  Eur J Clin Nutr       Date:  2017-02-01       Impact factor: 4.016

3.  Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study.

Authors:  Harvey J Murff; Xiao-Ou Shu; Honglan Li; Gong Yang; Xiauyan Wu; Hui Cai; Wanqing Wen; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cancer       Date:  2010-11-23       Impact factor: 7.396

4.  Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women.

Authors:  S Coosje Dijkstra; Johanna W Lampe; Roberta M Ray; Rose Brown; Chunyuan Wu; Wenjin Li; Chu Chen; Irena B King; Daoli Gao; Yongwei Hu; Jackilen Shannon; Kristiina Wähälä; David B Thomas
Journal:  J Nutr       Date:  2010-05-19       Impact factor: 4.798

5.  Involvement of dietary Fatty acids in multiple biological and psychological functions, in morbidly obese subjects.

Authors:  Anne Chalut-Carpentier; Zoltan Pataky; Alain Golay; Elisabetta Bobbioni-Harsch
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

6.  Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.

Authors:  Hye Jin Yoo; Minjoo Kim; Minkyung Kim; Minsik Kang; Keum Ji Jung; Se-Mi Hwang; Sun Ha Jee; Jong Ho Lee
Journal:  Metabolomics       Date:  2018-06-08       Impact factor: 4.290

7.  Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.

Authors:  Anuradha Budhu; Stephanie Roessler; Xuelian Zhao; Zhipeng Yu; Marshonna Forgues; Junfang Ji; Edward Karoly; Lun-Xiu Qin; Qing-Hai Ye; Hu-Liang Jia; Jia Fan; Hui-Chuan Sun; Zhao-You Tang; Xin Wei Wang
Journal:  Gastroenterology       Date:  2013-01-31       Impact factor: 22.682

8.  High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients.

Authors:  Ashley M Holder; Ana M Gonzalez-Angulo; Huiqin Chen; Argun Akcakanat; Kim-Anh Do; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi; Gordon B Mills; Funda Meric-Bernstam
Journal:  Breast Cancer Res Treat       Date:  2012-12-04       Impact factor: 4.872

9.  Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel.

Authors:  Isabel R Schlaepfer; Carolyn A Hitz; Miguel A Gijón; Bryan C Bergman; Robert H Eckel; Britta M Jacobsen
Journal:  Mol Cell Endocrinol       Date:  2012-08-16       Impact factor: 4.102

10.  Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial.

Authors:  P Bougnoux; N Hajjaji; M N Ferrasson; B Giraudeau; C Couet; O Le Floch
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.